selegiline has been researched along with gamma-aminobutyric acid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Rinne, UK | 1 |
| Colucci d'Amato, C; Cristillo, A; Puccini, A; Vizioli, R | 1 |
| Koulu, M; Lammintausta, R | 1 |
| Olpe, HR; Schellenberg, A | 1 |
| Czurkó, A; Faludi, B; Karádi, Z; Knoll, J; Lénárd, L; Niedetzky, C; Vida, I | 1 |
| Baker, GB; Todd, KG | 1 |
| Desser, H; Gerlach, M; Riederer, P; Youdim, MB | 1 |
| Commissiong, JW; Finberg, JP; Johnston, JM; Takeshima, T | 1 |
| Cano, J; de Pablos, RM; Herrera, AJ; Machado, A; Tomás-Camardiel, M | 1 |
| Cano, J; de Pablos, RM; Herrera, AJ; Machado, A; Navarro, A; Santiago, M; Tomás-Camardiel, M; Villarán, RF | 1 |
| Cho, J; Cho, S; Cho, SJ; Choi, JW; Chun, H; Hwang, SY; Jang, BK; Jo, S; Ju, YH; Kim, HJ; Kim, J; Kim, S; Kim, SW; Lee, C; Lee, CJ; Londhe, AM; Nam, MH; Oh, SJ; Pae, AN; Park, JH; Park, KD; Park, M; Shin, SJ; Song, HJ; Woo, J; Yarishkin, O; Yeon, SK | 1 |
| Gómez-Galán, M; Henning, L; Lindskog, M; Srivastava, I; Vazquez-Juarez, E | 1 |
| An, H; Cho, HU; Jang, DP; Kim, S; Lee, CJ; Nam, MH; Sim, J; Yang, S | 1 |
3 review(s) available for selegiline and gamma-aminobutyric acid
| Article | Year |
|---|---|
Recent advances in research on Parkinsonism.
Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1978 |
[Biochemical bases of Parkinson disease].
Topics: Acetylcholine; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Dopa Decarboxylase; Dopamine; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Receptors, Dopamine; Selegiline; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase | 1984 |
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.
Topics: Binding Sites; Clinical Trials as Topic; Corpus Striatum; Disease Progression; gamma-Aminobutyric Acid; Humans; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Neurotoxins; Nootropic Agents; Oxidative Stress; Parkinson Disease; Polyamines; Receptors, N-Methyl-D-Aspartate; Selegiline; Substantia Nigra | 1996 |
13 other study(ies) available for selegiline and gamma-aminobutyric acid
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteers.
Topics: Apomorphine; Bromocriptine; Dopamine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Levodopa; Phenethylamines; Receptors, Dopamine; Selegiline; Synapses | 1983 |
The sensitivity of cortical neurons to serotonin: effect of chronic treatment with antidepressants, serotonin-uptake inhibitors and monoamine-oxidase-blocking drugs.
Topics: Animals; Benzofurans; Cerebral Cortex; Clomipramine; Clorgyline; Desipramine; Electric Conductivity; gamma-Aminobutyric Acid; Male; Monoamine Oxidase Inhibitors; Neurons; Piperidines; Rats; Selegiline; Serotonin; Serotonin Antagonists | 1981 |
Responses of forebrain neurons to the MAO-B blocker L-deprenyl.
Topics: Acetylcholine; Amphetamine; Animals; Clorgyline; Electrophoresis; Female; gamma-Aminobutyric Acid; Macaca mulatta; Male; Microelectrodes; Monoamine Oxidase; Neurons; Prosencephalon; Rats; Rats, Inbred Strains; Selegiline; Species Specificity | 1995 |
GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
Topics: 4-Aminobutyrate Transaminase; Animals; Antidepressive Agents; Brain; Clorgyline; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenelzine; Premedication; Rats; Rats, Sprague-Dawley; Selegiline; Tranylcypromine | 1995 |
Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor.
Topics: Animals; Cell Survival; Cells, Cultured; Clorgyline; Dopamine; Embryo, Mammalian; gamma-Aminobutyric Acid; Indans; Mesencephalon; Methamphetamine; Microtubule-Associated Proteins; Monoamine Oxidase Inhibitors; Neurons; Rats; Rats, Sprague-Dawley; Selegiline; Tyrosine 3-Monooxygenase | 1998 |
Deprenyl enhances the striatal neuronal damage produced by quinolinic acid.
Topics: Animals; Antiparkinson Agents; Biomarkers; Calbindins; Corpus Striatum; Dopamine; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Situ Hybridization; Isoenzymes; Neurons; Oxidopamine; Parvalbumins; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Dopamine D2; S100 Calcium Binding Protein G; Selegiline; Sympatholytics; Tyrosine 3-Monooxygenase | 2005 |
Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
Topics: alpha-Methyltyrosine; Animals; Apoptosis; Astrocytes; Cell Respiration; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; gamma-Aminobutyric Acid; Male; Microglia; Mitochondria; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neurons; Nitro Compounds; Nomifensine; Oxygen Consumption; Propionates; Rats; Rats, Wistar; Reactive Oxygen Species; Reserpine; Selegiline; Succinate Dehydrogenase; Superoxides; Synaptosomes; Tyrosine 3-Monooxygenase; Up-Regulation | 2008 |
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Astrocytes; Cognitive Dysfunction; D-Amino-Acid Oxidase; Enzyme Inhibitors; gamma-Aminobutyric Acid; Humans; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline | 2019 |
Blocking Astrocytic GABA Restores Synaptic Plasticity in Prefrontal Cortex of Rat Model of Depression.
Topics: Animals; Astrocytes; Atrophy; Depression; Disease Models, Animal; gamma-Aminobutyric Acid; Long-Term Potentiation; Male; Neuronal Plasticity; Prefrontal Cortex; Rats, Sprague-Dawley; Receptors, GABA; Selegiline | 2020 |
Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis.
Topics: Animals; Clorgyline; Corpus Striatum; Dopamine; Female; gamma-Aminobutyric Acid; Male; Mice, Inbred C57BL; Molecular Imaging; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Patch-Clamp Techniques; Rats, Sprague-Dawley; Selegiline | 2021 |